Patients with lung cancer undergoing immune checkpoint inhibitors: A meta-analysis of dermatological toxicities
Author:
Funder
National Council for Scientific and Technological Development (CNPq), Brazil
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference67 articles.
1. Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis;Abdel-Rahman;Future Oncol.,2015
2. Association between skin reaction and clinical benefit in patients treated with anti-programmed cell death 1 monotherapy for advanced non-small cell lung Cancer;Aso;Oncologist,2019
3. Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: the Italian NSCLC expanded access program;Baldini;Lung Cancer.,2020
4. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor;Belum;Eur. J. Cancer,2016
5. Association of checkpoint inhibitor-induced toxic effects with shared Cancer and tissue antigens in non-small cell lung Cancer;Berner;JAMA Oncol.,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cutaneous adverse events in lung cancer patients on the therapy based on PD-1/PD-L1 inhibitors: A prospective observational cohort study;Current Problems in Cancer;2023-02
2. The influence of baseline characteristics on the efficacy of immune checkpoint inhibitors for advanced lung cancer: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-09-09
3. Toxic epidermal necrolysis induced by sintilimab in a patient with advanced non-small cell lung cancer and comorbid pulmonary tuberculosis: A case report;Frontiers in Immunology;2022-08-26
4. [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review;Actas Dermo-Sifiliográficas;2022-04
5. Knowledge, Attitude and Practice for Pruritus Management in Physicians and Patients with Diabetes;Clinics and Practice;2022-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3